Imation receives large order for Canadian PACS siteFilm and PACS vendor Imation has landed a large-scale PACS contract with the Manitoba healthcare system in Canada. The three-year pilot project, valued at $5 million (Canadian), for PACS, as
Film and PACS vendor Imation has landed a large-scale PACS contract with the Manitoba healthcare system in Canada. The three-year pilot project, valued at $5 million (Canadian), for PACS, as well as associated wide-area networking equipment, will link up two Winnipeg teaching hospitals-St. Boniface General Hospital and Health Sciences Centre-with Grace Hospital in Ottawa, two rural hospitals, a clinic, and selected on-call physicians, according to Imation. The Canadian federal government and the Manitoba provincial government will each contribute $1.25 million toward the $5 million contract.
As part of the contract, Imation engineers will be working on-site at St. Boniface General Hospital to interface Imation's PACS to a wide-area network powered by high-speed asymmetric digital subscriber lines (ADSL). ADSL is a switching technology that utilizes existing copper telephone lines to rapidly transfer large-bandwidth files. St. Boniface plans to employ ADSL lines running at 1 MB per second, according to Imation of Oakdale, MN. Manitoba Telecom Services and St. Boniface General Hospital Research Centre will also be contributing to the project development effort.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.